html How to choose the best omega-3 for your goal: 9 criteria
Content based on scientific studies and verifiable data.Updated: September 2026
Buying guide

How to choose an omega-3 using objective criteria.

Nine objective criteria for comparing different products on the same basis.

Important shortcut: between an EE capsule and a TG liquid with polyphenols, the second combination starts with an advantage on two important points: TG form and antioxidant protection.
Criterion 1

Actual EPA + DHA per dose

Compare the milligrams of EPA+DHA actually consumed per day. To compare products fairly, use EPA+DHA per daily dose — not just total milligrams of oil.

Criterion 2

Chemical form

Prefer forms with more favorable bioavailability. In comparative studies, TG/rTG forms tend to produce greater EPA+DHA incorporation than EE when other conditions are similar.

Criterion 3

Protection against oxidation

EPA and DHA are sensitive lipids. An antioxidant-rich matrix, such as one containing polyphenols, is a relevant advantage.

Criterion 4

Practical dose

A concentrated liquid dose can deliver a meaningful amount of EPA+DHA without requiring multiple capsules.

Criterion 5

Purity and freshness

Oil quality influences how much reaches the body intact.

Criterion 6

Testing and follow-up

Measuring baseline status and retesting confirms whether the strategy changed the fatty-acid profile.

Criterion 7

Cost per useful dose

Compare cost per gram of EPA+DHA, not just the price of the bottle.

Criterion 8

Additional ingredients

Polyphenols and antioxidants such as vitamin E add value mainly by protecting the formulation against oxidation; vitamins D and E can also add nutritional value.

Criterion 9

Adherence

The best product needs to be simple enough to use consistently.

Use these criteria together with the EPA and DHA e with o dose and cost comparator. To see these criteria applied to a TG liquid formulation with polyphenols, continue to how to buy a better omega-3. To go deeper into the evidence and see presentations by topic, explore the Omega-3 Science Library.

Scientific evidence

Studies, cohorts, trials and reviews supporting the main points on this page.

  1. Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010;83(3):137-141. doi:10.1016/j.plefa.2010.06.007. PMID:20638827
  2. Neubronner J, Schuchardt JP, Kressel G, Merkel M, von Schacky C, Hahn A. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from re-esterified triglycerides versus ethyl esters. Eur J Clin Nutr. 2011;65(2):247-254. PMID:21063431
  3. Minton ST, et al. Comparative membrane incorporation of omega-3 fish oil formulations with different re- esterified triglyceride content. Nutrients. 2023;15. PMID:36706088
  4. Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 formulations. Lipids Health Dis. 2011;10:145. doi:10.1186/1476-511X-10-145. PMID:21854650
  5. Lawson LD, Hughes BG. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem Biophys Res Commun. 1988;152(1):328-335. PMID:2847723
  6. Raatz SK, Johnson LK, Rosenberger TA, Picklo MJ. Enhanced bioavailability of EPA from emulsified fish oil preparations versus capsules. Prostaglandins Leukot Essent Fatty Acids. 2016;113:15-21. PMID:26688435
  7. Bremmell KE, et al. A self-emulsifying omega-3 ethyl ester formulation improves EPA and DHA bioavailability. Eur J Clin Nutr. 2020;74:423-430. PMID:31637467
  8. Jackowski SA, Alvi AZ, Mirajkar A, et al. Oxidation levels of North American over-the-counter n-3 supplements and the influence of supplement formulation and delivery form. J Nutr Sci. 2015;4:e30. doi:10.1017/jns.2015.21. PMID:26688721
  9. Albert BB, Cameron-Smith D, Hofman PL, Cutfield WS. Oxidation of marine omega-3 supplements and human health. Biomed Res Int. 2013;2013:464921. doi:10.1155/2013/464921. PMID:23738326
  10. Flock MR, Skulas-Ray AC, Harris WS, et al. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation. Am J Clin Nutr. 2013;97(4):808-817. PMID:23426033
  11. Walker RE, Jackson KH, Tintle NL, Shearer GC, Bernasconi A, Masson S, Latini R, Heydari B, Kwong RY, Flock M, Kris-Etherton PM, Harris WS. Predicting the effects of supplemental EPA and DHA on the Omega-3 Index. Am J Clin Nutr. 2019;110(4):1034-1040. doi:10.1093/ajcn/nqz161. PMID:31396625

View the complete scientific library →